Bill Text: NY A09982 | 2023-2024 | General Assembly | Introduced


Bill Title: Requires nightlife establishments, sporting or event centers, theaters, concert venues, and amusement parks maintain a supply of opioid antagonists.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-05-01 - referred to health [A09982 Detail]

Download: New_York-2023-A09982-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                          9982

                   IN ASSEMBLY

                                       May 1, 2024
                                       ___________

        Introduced  by M. of A. JACKSON -- read once and referred to the Commit-
          tee on Health

        AN ACT to amend the public health law, in relation to requiring  certain
          locations and venues maintain a supply of opioid antagonists

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 8 of section 3309 of the public health law,  as
     2  added by chapter 83 of the laws of 2023, is amended to read as follows:
     3    8. The commissioner shall establish guidelines for onsite opioid over-
     4  dose  response  capacity  in nightlife establishments, sporting or event
     5  centers, theaters, concert venues, and amusement parks. Such  guidelines
     6  shall include, but shall not be limited to:
     7    (a)  maintaining  a supply of unexpired opioid antagonist nasal spray;
     8  and
     9    (b) having employed and at such  location  whenever  in  operation  at
    10  least  two  persons  trained  in  identifying opioid overdoses and using
    11  opioid antagonists.
    12    § 2. This act shall take effect on the ninetieth day  after  it  shall
    13  have become a law.






         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14868-01-4
feedback